Zekai Li

Mr. Zekai Li

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2023 in Cancers
Verified
Journal Article
Open access
PDF file
MRMostafa Roya
Mostafa Roya
SMSamaneh Mostafapour
Samaneh Mostafapour
PMPhilipp Mohr
Philipp Mohr
LPLaura Providência
Laura Providência
ZLZekai Li
Zekai Li
Joyce van SluisJoyce van Sluis
Joyce van Sluis
The latest technical development in the field of positron emission tomography/computed tomography (PET/CT) imaging has been the extension of the PET axial field-of-view. As a result of the increased number of detectors, the long axial field-of-view (LAFOV) PET systems are not only characterized by a larger anatomical coverage but also by a substantially improved sensitivity, compared with conventional short axial field-of-view PET systems. In clinical practice, this innovation has led to the following optimization: (1) improved overall image quality, (2) decreased duration of PET examinations, (3) decreased amount of radioactivity administered to the patient, or (4) a combination of any of the above. In this review, novel applications of LAFOV PET in oncology are highlighted and future directions are discussed.

1 March 2026 in IEEE Transactions on Radiation and Plasma Medical Sciences
Verified
Journal Article
Closed access
ZLZekai Li
Zekai Li
PMPhilipp Mohr
Philipp Mohr
VDViet Dao
Viet Dao
GLGert Luurtsema
Gert Luurtsema
ABAdrienne Brouwers
Adrienne Brouwers
CTCharalampos Tsoumpas
Charalampos Tsoumpas
Simultaneous dual-tracer positron emission tomography (PET) allows for the measurement of two distinct physiological processes within a single scan, i.e. under identical biological conditions. Quantification of 89Zr-labeled monoclonal antibody (89ZrmAb) uptake can be influenced by perfusion. Perfusion can be measured using 15.OH2O PET, but considerable variability in perfusion between scans may be an issue, there is a need to measure it at the same time as 89ZrmAb uptake. Based on the high sensitivity of long axial field-of-view (LAFOV) PET, this simulation study uses digital twins based on real patient scans to evaluate the feasibility of 15OH2O and 89ZrmAb dual-tracer imaging. Using a 15-minute scanning protocol, kinetic-based and subtraction-based methods were employed to recover 15OH2O kinetic parameters (K1 and VT) at both volume-of-interest (VOI) and voxel levels for various tracer uptake scenarios. Quantitative assessment was carried out using scatter and Bland-Altman plots by comparing 15OH2O parameters derived from a dual-tracer scan with those derived from the corresponding single tracer 15OH2O results. Both methods showed excellent recovery of 15OH2O kinetic parameters, with correlation coefficients exceeding 0.99 for VOI-level estimates and 0.94 for voxel-level estimates. Performance was further validated through bias versus standard deviation analyses. This study demonstrates the feasibility of a clinically practical 15-minute protocol for a simultaneous 15OH2O and 89ZrmAb PET acquisition while retaining accuracy of 15OH2O quantification.

10 August 2026 in The EANM Journal
Verified
Journal Article
Open access
ZLZekai Li
Zekai Li
ADAvishan Elkayee Dehno
Avishan Elkayee Dehno
JSJoyce van Sluis
Joyce van Sluis
NENikos Efthimiou
Nikos Efthimiou
GSGilles Stormezand
Gilles Stormezand
CTCharalampos Tsoumpas
Charalampos Tsoumpas

5 February 2026 in Journal of Nuclear Medicine
Verified
Journal Article
Open access
ZLZekai Li
Zekai Li
LPLaura Providência
Laura Providência
PMPhilipp Mohr
Philipp Mohr
SMSamaneh Mostafapour
Samaneh Mostafapour
MRMostafa Roya
Mostafa Roya
CTCharalampos Tsoumpas
Charalampos Tsoumpas
The advent of long-axial-field-of-view (LAFOV) PET/CT systems has significantly improved whole-body imaging by providing higher sensitivity and extended torso coverage. However, PET/CT potential misalignment remains a challenge, potentially introducing artifacts and quantification errors. Moreover, PET protocols with reduced scanning duration and dose, as well as the use of ultra-low-dose CT (ULD-CT), are increasingly relevant in clinical practice and research. This study aimed to evaluate the robustness and generalizability of a deep-learning coregistration framework for PET/CT alignment using low-dose PET and ULD-CT across various tracers with a LAFOV system. Methods: In total, 63 scans with 4 different tracers (89Zr-trastuzumab, 15O-H2O, 18F-MC225, and 18F-FDG) were included to assess PET and CT alignment improvements. Further evaluation was performed by comparing CT scans coregistered to the original PET images (rCT) with those coregistered to low-count (50%, 25%, and 12.5% of original counts) PET images (LC-rCT). Dice similarity coefficient, Jaccard similarity coefficient, Hausdorff distance, and average surface distance were used as evaluation metrics. Furthermore, ULD-CT coregistered to PET (rULD-CT) was compared with low-dose CT coregistered to the same PET (rLD-CT) using the same metrics. PET accuracy was evaluated by calculating SUVs. Results: The robustness of the deep-learning coregistration framework was demonstrated in reduced PET counts and ULD-CT scenarios across tracers. All metrics indicated robust performance when comparing LC-rCT with rCT and rULD-CT with rLD-CT. Consistent SUVs across varying PET counts and ULD-CT conditions further validated the quantitative accuracy of the approach. Conclusion: This work highlights that neither the use of low-dose PET protocols nor ULD-CT compromise the performance of this coregistration framework across 4 tracers. For LAFOV PET, these findings support the feasibility of such a framework in imaging protocols with reduced radiation exposure.